#BeyondtheData at #TCT2024: Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, and Bernard Prendergast discuss the case for intervening earlier in aortic stenosis. Watch the full video here: https://lnkd.in/gK7s3j32
关于我们
egnite is a visionary digital health company committed to advancing the health of our society through innovative cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company partners with leading hospitals and life sciences organizations to transform care delivery for cardiovascular patients. Led by President & CEO Joel Portice, egnite has a tenured executive leadership team with deep experience in artificial intelligence and big data analytics. We are aware of fraudulent recruiting activity by individuals impersonating egnite. egnite exclusively posts available opportunities on LinkedIn. Any interviews will be scheduled by egnite’s Vice President of People and Culture, egnite’s Human Resources Specialist, or a recruitment firm that partners with egnite. All interviews will be conducted by phone or video interview, and egnite and our recruitment partners will never ask you to complete an interview through email. Please report any suspicious recruiting activities to [email protected]. Community Guidelines: In order to create a positive and engaging environment in the egnite social media community, we ask all users to treat each other with respect and stay on topic. Users may disagree with an idea; however, they must be respectful of others at all times. Insults, threats or harassment of other users, organizations or employees are prohibited. egnite will not tolerate and reserves its right to delete - to the full extent that each respective social media platform allows - any post or comment that: - is defamatory, indecent, hateful, racist, xenophobic, homophobic, sexist, disgraceful, vulgar or inappropriate; - encourages or suggests illegal activity, announcements from labor or political organizations and unintelligible or irrelevant posts. - Threadjacks, or promotes false news or violence
- 网站
-
https://egnitehealth.com
egnite Health的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Aliso Viejo，CA
- 类型
- 私人持股
- 创立
- 2021
- 领域
- Medical Device、Structural Heart Disease、Artificial Intelligence、Cardiovascular Disease和Healthcare
地点
-
主要
获取路线
65 Enterprise
Suite 455
US，CA，Aliso Viejo，92656
egnite Health员工
动态
-
New real-world data from Philippe Généreux Genereux using egnite's Database demonstrated improved survival in asymptomatic aortic stenosis patients undergoing AVR. Data uncover 3x improved survival for asymptomatic AS patients treated with AVR versus AS patients with acute valve syndrome. Congratulations to all of the authors, including: Patricia Pellikka, MD Lindman Brian Philippe PibarotSantiago Garcia Evelio Rodriguez Vinod Thourani Mike Dobbles Gennaro Giustino, MD Rahul Sharma David Cohen Linda Gillam, MD, MPH ?? the science here: https://bit.ly/4fioTRw #Cardiology #Research #AorticStenosis
-
-
We've partnered with Philippe Généreux using egnite's multi-center real-world data to uncover clinical presentation trends for patients with aortic stenosis. Join us for the presentation at #TCT2024 this Monday! https://bit.ly/3YeWvca #Cardiology #Research #AorticStenosis
-
-
"We purchased the ‘best’ version of our EMR, and when we utilized the original criteria, we identified few possible LAAC candidates, whereas your software helped to identify many good candidates. It speaks volumes to CardioCare’s ability to identify patients more precisely than the EMR." Chat with us to learn how egnite can help you find the right patients at the right time. https://ow.ly/SjNL50RC2vp
-
-
A mid-sized #HealthSystem ?? used the CardioCare platform to establish their #Cardiovascular ?? program as a referral destination for high-quality care, identifying and navigating 43 patients across valve disease, heart failure, and atrial fibrillation through to an intervention in just 7 months. Read the Case Study: https://lnkd.in/gZ3A-UEm #DigitalHealth
-
We're excited to see new medical therapy options ?? for hypertrophic cardiomyopathy with class 1 recommendations in the newly released 2024 guidelines for management. https://ow.ly/4L7050RGmT4 #Cardiology
-
Congratulations to ?? John Mignone MD, PhD, Kevin Alexander, Gregg Fonarow, MD, FACC, Kenneth Ellenbogen on their recently published manuscript in Heart Rhythm O2. These insights demonstrate real-world trends in heart failure patient care and further suggest the benefits of combined device therapy and contemporary guideline-directed medical therapy. Read the full study: https://lnkd.in/gaf34PTZ #HeartFailure #DigitalHealth
-
"In heart failure, data is your friend. It gives us benchmarks, helps identify patients for outreach, and allows us to proactively manage this population to optimal medical therapy and treatment." Lauren Lindner and Dr. Shane LaRue speak to their experience at St. Luke's Hospital with the CardioCare platform. #DigitalHealth #Cardiology #HeartFailure https://lnkd.in/gkbCWc9e
-
Recent FDA approval of TriClip provides more great options for patients in the US with tricuspid regurgitation! ?? https://ow.ly/84tu50RtEly #TricuspidRegurgitation #Cardiology
FDA Approves TriClip TEER Device for Tricuspid Repair
tctmd.com
-
As the #DigitalHealth industry continues to grow, egnite is leading innovation in #Cardiolovascular patient management and data analytics. We are honored to have been named to Newsweek and Statista's list of World’s Best Digital Health Companies for 2024! ?? https://ow.ly/BW4e50Rpn7M
World's Best Digital Health Companies 2024
newsweek.com